MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
716.72
+19.67
+2.82%
Pre Market: 715.21 -1.51 -0.21% 04:17 02/06 EST
OPEN
708.80
PREV CLOSE
697.05
HIGH
729.25
LOW
700.01
VOLUME
1
TURNOVER
803.81M
52 WEEK HIGH
1,211.20
52 WEEK LOW
642.00
MARKET CAP
77.46B
P/E (TTM)
18.70
1D
5D
1M
3M
1Y
5Y
1D
Regeneron Is Playing Defense With Capital Allocation
Seeking Alpha · 1d ago
Alphabet, Disney report quarterly beats: Morning Buzz
TipRanks · 1d ago
Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval
NASDAQ · 1d ago
Regeneron upgraded at Leerink following recent share weakness
Seeking Alpha · 1d ago
EyePoint stock jumps 10% on Duravyu study results
Seeking Alpha · 1d ago
Regeneron Pharma Is Maintained at Neutral by Baird
Dow Jones · 1d ago
Regeneron Pharma Price Target Cut to $759.00/Share From $940.00 by Baird
Dow Jones · 1d ago
AMD, Spotify downgraded: Wall Street’s top analyst calls
TipRanks · 1d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company helps in accelerating and improving the traditional drug development process through its VelociSuite technologies, such as VelocImmune, which uses genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center. Its marketed products include EYLEA (aflibercept) Injection; Dupixent (dupilumab) Injection; Libtayo (cemiplimab) Injection; Praluent (alirocumab) Injection; Kevzara (sarilumab) Injection, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.